Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
2.
ISRN Pharm ; 2012: 125864, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22500243

RESUMO

ß-Glucans extracted from barley, which mainly contains ß-(1,3-1,4)-D-glucan, are used extensively as supplements and food additives due to their wide biologic activities, including a reduction in blood lipid level. In this study, the antioxidant activity of ß-glucan was examined to assess potential new benefits associated with ß-glucan, because oxidative stress is considered one of the primary causal factors for various diseases and aging. ß-Glucan extracted from barley was found to possess significant antioxidant activity. The amount of antioxidant activity was influenced by different physiologic properties (e.g., structure and molecular size) of ß-glucan, which varied depending on the source and extraction method used. The antioxidant activity of ß-glucan was significantly higher than that of various polymers that are used as food additives. These results indicate that ß-glucan has promise as a polymeric excipient for supplement and food additive with antioxidant and other benefits, which may contribute to enhancing health and beauty.

3.
J Toxicol Sci ; 33(3): 307-14, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18670162

RESUMO

Effects of dose and duration of phenobarbital (PB) administration and those of co-administration of PB and vitamin K on blood coagulation-related parameters were examined in specific pathogen-free (SPF) rats of Sprague-Dawley strain kept on an ordinary diet. In Experiment 1, oral administration of PB (0, 25, 50, 100 or 150 mg/kg/day) for 2 weeks induced increases in hepatic cytochrome P450 content and CYP2B expression, prolongation of coagulation time (activated partial thromboplastin time (APTT) and Thrombotest (TBT)) and an increase in anti-thrombin III (AT III) concentration in a dose-dependent manner. In Experiment 2, PB administration (100 mg/kg/day) for up to 14 days produced time-dependent increases in hepatic cytochrome P450 content and CYP2B (CYP2B1 and CYP2B2) expression. APTT was prolonged from day 1 and AT III concentration was increased from day 2, whereas the coagulation time (TBT) was prolonged from day 7. In Experiment 3, APTT prolonged by PB (100 mg/kg/day) was shortened after vitamin K(2) (30 mg/kg/day) co-administration, although AT III concentration was still increased. This suggests that not AT III but PB-induced vitamin K deficiency may play an important role in PB-induced prolongation of coagulation time in SPF rats kept on an ordinary diet.


Assuntos
Coagulação Sanguínea/efeitos dos fármacos , Fenobarbital/toxicidade , Vitamina K/farmacologia , Animais , Antitrombina III/análise , Antitrombina III/fisiologia , Relação Dose-Resposta a Droga , Masculino , Tempo de Tromboplastina Parcial , Ratos , Ratos Sprague-Dawley , Organismos Livres de Patógenos Específicos , Vitamina K/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA